Dr Yi Ye and Dr Vanessa Uzonwan examine research that suggests how cancer drugs may be repurposed to manage oral cancer pain.  Cancer-associated pain remains a major clinical challenge, particularly in oral squamous cell carcinoma (OSCC), where patients experience severe pain during eating and speaking alongside substantial declines in quality of life. Despite advances in pain research, management still relies largely […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!